MSK 2022 Developmental Oncology Symposium

MSK 2022 Developmental Oncology Symposium is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held from May 02 - 03, 2022 at Memorial Sloan Kettering Cancer Center - Zuckerman Research Center, New York City, New York, United States of America.

Who Should Attend:
The target audience for this symposium includes scientists, physicians, APPs, nurses, and other healthcare providers interested in learning the latest advances in our understanding of the biology and therapy of childhood cancers. We are pleased to invite students and trainees to attend this symposium on a complimentary basis .

Overview:
The 2022 Developmental Oncology Symposium will bring together outstanding scientists from across the country to discuss the latest discoveries into the molecular mechanisms of cancers in children and young adults and the development of new approaches for their definitive therapy and control. The symposium is the first of its kind which is dedicated to new science at the interface of human development and cancer pathogenesis. This program will feature interactive discussions of fundamental and translational research to address unanswered questions in the field of developmental oncology.

There are many unanswered questions that need to be addressed for childhood and young adult cancers:
• What causes cancer in children and young adults without inheritance of cancer-predisposing mutations or exposure to environmental mutagens? How do predisposing alleles and exposures contribute to cancer development?
• What developmental processes are dysregulated to cause mutations and cell transformation in otherwise healthy tissues?
• How do mutations in developmental pathways involving transcription factors and epigenetic signaling cause cancer?
• How do we design effective therapeutics to block, activate, and modulate protein interactions that control transcription factors and other developmental regulators?
• How do we identify targets for immune therapy in developmental tumors that have relatively few mutations?

This two-day live in-person symposium will provide an intimate and exciting setting to share new advances for these questions. It will also allow an opportunity for established and young investigators to discuss new questions and interdisciplinary approaches of relevance to young-onset cancer biology. A complete agenda will be available in February 2022.

Objectives:
• Explain biologic and developmental causes of childhood cancers.
• Review recently developed therapies for patients with childhood and young-onset cancers.
• Discuss new biologic questions in order to accelerate the development of definitive therapies for patients.